TapewireFind a company

person · Reporting owner

HACKETT PATRICK T

Disclosed activity across 2 companies

Tapewire entity
40905
SEC CIK
0001238606

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Outset Medical, Inc.OM · Entity 7026DirectorJune 04, 2026June 05, 2026
Zovio IncBPI · Entity 124041DirectorMay 31, 2017May 31, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Outset Medical, Inc.

Report date June 04, 2026 · Filed June 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect105,839 Reported balance After 2026-06-04 transaction · row 1
1 source row

Row 1 · 2026-06-04 · Grant · Acquired 10,667 · Balance 105,839

F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Common StockSEC Table I · non-derivativeIndirectGST Trust83,333 Reported balance Holding disclosure · report date 2026-06-04 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 83,333

Common StockSEC Table I · non-derivativeIndirectHackett Family Fund41,666 Reported balance Holding disclosure · report date 2026-06-04 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 41,666

Filing footnotes · ownership attribution and instrument terms

F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Zovio Inc

Report date May 31, 2017 · Filed May 31, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitSEC Table II · derivative / convertible securityDirect1,780 Reported balance After 2017-05-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2017-05-31 · Grant · Acquired 1,780 · Balance 1,780

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 04, 2026 Filed Jun 5, 2026 22:59 UTC Outset Medical, Inc. OM · Entity 7026 GrantCommon Stock 10,667 $0.00 $0.00
Disclosure

SEC source: 0001484612-26-000039 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,839

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:26 UTC Outset Medical, Inc. OM · Entity 7026 GrantCommon Stock 8,983 $0.00 $0.00
Disclosure

SEC source: 0001484612-25-000055 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,172

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

F2 · balance_after: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split").

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 Exercise / conversionSeries A Non-Voting Convertible Preferred · Derivative 2,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 9

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Hackett Family Fund

Disclosed balance after: 0

Underlying: Preferred Stock · 2,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 Exercise / conversionSeries A Non-Voting Convertible Preferred · Derivative 5,000 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 7

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · GST Trust

Disclosed balance after: 0

Underlying: Preferred Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 Exercise / conversionSeries A Non-Voting Convertible Preferred · Derivative 5,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 5

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Preferred Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 Exercise / conversionCommon Stock 625,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · nonDerivative · entry 3

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Hackett Family Fund

Disclosed balance after: 625,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 Exercise / conversionCommon Stock 1,250,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · nonDerivative · entry 2

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · GST Trust

Disclosed balance after: 1,250,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 Exercise / conversionCommon Stock 1,250,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,292,849

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 GrantSeries A Non-Voting Convertible Preferred · Derivative 2,500 $200.00 Strike: $0.00 $500,000.00
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 8

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Hackett Family Fund

Disclosed balance after: 2,500

Underlying: Preferred Stock · 2,500 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 GrantSeries A Non-Voting Convertible Preferred · Derivative 5,000 $200.00 Strike: $0.00 $1,000,000.00
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 6

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · GST Trust

Disclosed balance after: 5,000

Underlying: Preferred Stock · 5,000 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:19 UTC Outset Medical, Inc. OM · Entity 7026 GrantSeries A Non-Voting Convertible Preferred · Derivative 5,000 $200.00 Strike: $0.00 $1,000,000.00
Disclosure

SEC source: 0001484612-25-000034 · edgardoc.xml · derivative · entry 4

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Preferred Stock · 5,000 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

Read SEC document
May 29, 2024 Filed May 29, 2024 23:10 UTC Outset Medical, Inc. OM · Entity 7026 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000052 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,849

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2023 Filed May 31, 2023 23:08 UTC Outset Medical, Inc. OM · Entity 7026 GrantCommon Stock 7,681 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000046 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,849

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2022 Filed Jun 1, 2022 20:23 UTC Outset Medical, Inc. OM · Entity 7026 GrantCommon Stock 6,880 $0.00 $0.00
Disclosure

SEC source: 0001484612-22-000046 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,168

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
June 03, 2021 Filed Jun 4, 2021 21:02 UTC Outset Medical, Inc. OM · Entity 7026 GrantCommon Stock 3,288 $0.00 $0.00
Disclosure

SEC source: 0001484612-21-000021 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,288

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 31, 2017 Filed May 31, 2017 18:50 UTC Zovio Inc BPI · Entity 124041 GrantRestricted Stock Unit · Derivative 1,780 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-023164 · doc1.xml · derivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,780

Underlying: Common Stock · 1,780 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018.

F2 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on May 31, 2018.

Read SEC document
March 29, 2017 Filed Mar 31, 2017 19:53 UTC Zovio Inc BPI · Entity 124041 Exercise / conversionRestricted Stock Unit · Derivative 2,900 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-014231 · doc1.xml · derivative · entry 5

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F8 · derivative.exercise_date: On March 29, 2017, 100% of the restricted stock units vested and were settled for an equal number of shares of the issuer's common stock.

F8 · derivative.expiration_date: On March 29, 2017, 100% of the restricted stock units vested and were settled for an equal number of shares of the issuer's common stock.

Read SEC document
March 29, 2017 Filed Mar 31, 2017 19:53 UTC Zovio Inc BPI · Entity 124041 GrantRestricted Stock Unit · Derivative 2,840 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-014231 · doc1.xml · derivative · entry 4

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,840

Underlying: Common Stock · 2,840 shares

Expires not disclosed

F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F7 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2018.

F7 · derivative.expiration_date: Subject to the reporting person's continuing service, 100% of the restricted stock units shall vest on March 29, 2018.

Read SEC document
March 29, 2017 Filed Mar 31, 2017 19:53 UTC Zovio Inc BPI · Entity 124041 GrantStock Option (right to buy) · Derivative 6,100 $0.00 Strike: $10.44 $0.00
Disclosure

SEC source: 0001140361-17-014231 · doc1.xml · derivative · entry 3

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,100

Underlying: Common Stock · 6,100 shares

Expires 2027-03-29

F5 · derivative.exercise_date: Subject to the reporting person's continuing service, 100% of the shares subject to the option shall vest and become exercisable on March 29, 2018.

Read SEC document
March 29, 2017 Filed Mar 31, 2017 19:53 UTC Zovio Inc BPI · Entity 124041 Exercise / conversionCommon Stock 2,900 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-014231 · doc1.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On March 29, 2017, 2,900 of the reporting person's restricted stock units were settled for an equal number of shares of the issuer's common stock.

Read SEC document
March 10, 2017 Filed Mar 14, 2017 17:01 UTC Zovio Inc BPI · Entity 124041 Disposition to issuerCommon Stock, par value $0.01 per share (''Common Stock'') 18,072,289 $8.30 $149,999,998.70
Disclosure

SEC source: 0001104659-17-016395 · a4.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 9,638,285

F1 · kind: The reported securities were sold in connection with the repurchase of Common Stock from Warburg Pincus Private Equity VIII, L.P., by Bridgepoint Education, Inc. (the "Company"), pursuant to the Share Repurchase Agreement by and between Warburg Pincus Private Equity VIII, L.P. and the Company, dated as of March 10, 2017. Pursuant to such agreement, Warburg Pincus Private Equity VIII, L.P sold 18,072,289 shares of Common Stock of the Company at $8.30 per share on March 10, 2017.

F2 · ownership.nature: Reflects the Common Stock held by Warburg Pincus Private Equity VIII, L.P., a Delaware limited partnership (together with its two affiliated partnerships, "WP VIII"). The reporting person is a director of the Company, Member and Managing Director of Warburg Pincus LLC, a New York limited liability company ("WP LLC"), and a Partner of Warburg Pincus & Co., a New York general partnership ("WP"). Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the general partner, both directly and indirectly, of WP VIII. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners. WP is the managing member of WP Partners GP.

F3 · ownership.nature: WP LLC is the manager of WP VIII. As a result, the reporting person may be deemed to have an indirect pecuniary interest (within the meaning of Rule 16a-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) in an indeterminate portion of the securities that may be deemed to be beneficially owned by WP VIII, WP Partners, WP Partners GP, WP and WP LLC (collectively, the "Warburg Pincus Entities").

F4 · ownership.nature: All shares of Common Stock indicated as indirectly owned by Mr. Hackett are included because of his affiliation with the Warburg Pincus Entities. The reporting person disclaims beneficial ownership of all securities that may be deemed to be beneficially owned by the Warburg Pincus Entities, except to the extent of any indirect pecuniary interest therein. This Form 4 shall not be deemed an admission that the reporting person or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Exchange Act or for any other purposes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.